Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celecure Ltd.
DescriptionSoluble recombinant fragment of human protein CD44
Molecular Target CD44
Mechanism of ActionAngiogenesis inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today